Richard J. Ablin,
Malcolm D. Mason
Springer Netherlands
e druk, 2014
9789401781527
Metastasis of Prostate Cancer
Specificaties
Paperback, blz.
|
Engels
Springer Netherlands |
e druk, 2014
ISBN13: 9789401781527
Rubricering
Onderdeel van serie
Cancer Metastasis - Biology and Treatment
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This volume brings together the key research issues in clinical and laboratory science relating to metastasis in prostate cancer. Coverage ranges from the most fundamental aspects of the molecular biology of metastasis, to the patient in the clinic. The therapeutic approaches range from conventional drug design to immunogene therapy. Prostate cancer is an area of intense research effort, and this book provides a window on contemporary research in this important area.
Specificaties
ISBN13:9789401781527
Taal:Engels
Bindwijze:paperback
Uitgever:Springer Netherlands
Inhoudsopgave
<P>Chapter 1: Introduction: Metastasis as a Therapeutic Target<BR>Richard J. Ablin and Malcolm D. Mason</P>
<P>Chapter 2: The Natural History of Prostate Cancer<BR>David F. Penson and Peter C. Albertsen</P>
<P>Chapter 3: The Search for Genes Which Influence Prostate Cancer Metastasis: A Moving Target?<BR>Norman J. Maitland</P>
<P>Chapter 4: Polyunsaturated Fatty Acids and Prostate Cancer Metastasis<BR>Wen G. Jiang</P>
<P>Chapter 5: Role of Prostaglandin Synthesis and Cyclooxygenase-2 in Prostate Cancer and Metastasis<BR>Alaa F. Badawi</P>
<P>Chapter 6: Cell Cycle Regulation<BR>Ruchi M. Newman and Bruce R. Zetter</P>
<P>Chapter 7: Epithelial-Mesenchymal Molecular Interactions in Prostatic Tumor Cell Plasticity<BR>Mary J.C. Hendrix, Jun Luo, Elisabeth A. Seftor, Navesh Sharma, Paul M. Heidger<BR>Jr., Michael B. Cohen, Robert Bhatty, Jirapat Chungthapong, Richard E.B. Seftor, and David Lubaroff</P>
<P>Chapter 8: Orthotopic Metastatic Mouse Models of Prostate Cancer<BR>Robert M. Hoffman</P>
<P>Chapter 9: ß-Catenin, its Binding Partners and Signalling Mechanisms: Implications in Prostate Cancer<BR>Gaynor Davies, Gregory M. Harrison, and Malcolm D. Mason</P>
<P>Chapter 10: Hepatocyte Growth Factor/Scatter Factor and Prostate Cancer Metastasis<BR>Gaynor Davies, Wen G. Jiang, and Malcolm D. Mason</P>
<P>Chapter 11: Matrix Degradation in Prostate Cancer<BR>Michael J. Wilson and Akhouri A. Sinha</P>
<P>Chapter 12: The Biology of Bone Metastases from Prostate Cancer and the Role of Bisphosphonates<BR>Noel W. Clarke and Herbert A. Fleisch</P>
<P>Chapter 13: Non-Steroidal Anti-Androgen Use as Part of Combined Androgen Blockade Therapy for Metastatic or Locally Advanced Prostate Cancer: a Review of the Evidence on Efficacy and Toxicity<BR>Mike Shelley, Charles Bennett, Derek Nathan, and Oliver Sartor</P>
<P>Chapter 14: Strategies for the Implementation of Chemotherapy and Radiotherapy<BR>Paula Scullin, Joe M. O’Sullivan, and Christopher C. Parker</P>
<P>Chapter 15: Immuno-gene Therapy for Metastatic Prostate Cancer<BR>Takefumi Satoh, Terry L. Timme, Yehoshua Gdor, Brian J. Miles, Robert J. Amato, Dov Kadmon, and Timothy C. Thompson</P>
<P>Chapter 16: Distilling the Past – Envisioning the Future<BR>Richard J. Ablin and Malcolm D. Mason</P>
<P>Chapter 2: The Natural History of Prostate Cancer<BR>David F. Penson and Peter C. Albertsen</P>
<P>Chapter 3: The Search for Genes Which Influence Prostate Cancer Metastasis: A Moving Target?<BR>Norman J. Maitland</P>
<P>Chapter 4: Polyunsaturated Fatty Acids and Prostate Cancer Metastasis<BR>Wen G. Jiang</P>
<P>Chapter 5: Role of Prostaglandin Synthesis and Cyclooxygenase-2 in Prostate Cancer and Metastasis<BR>Alaa F. Badawi</P>
<P>Chapter 6: Cell Cycle Regulation<BR>Ruchi M. Newman and Bruce R. Zetter</P>
<P>Chapter 7: Epithelial-Mesenchymal Molecular Interactions in Prostatic Tumor Cell Plasticity<BR>Mary J.C. Hendrix, Jun Luo, Elisabeth A. Seftor, Navesh Sharma, Paul M. Heidger<BR>Jr., Michael B. Cohen, Robert Bhatty, Jirapat Chungthapong, Richard E.B. Seftor, and David Lubaroff</P>
<P>Chapter 8: Orthotopic Metastatic Mouse Models of Prostate Cancer<BR>Robert M. Hoffman</P>
<P>Chapter 9: ß-Catenin, its Binding Partners and Signalling Mechanisms: Implications in Prostate Cancer<BR>Gaynor Davies, Gregory M. Harrison, and Malcolm D. Mason</P>
<P>Chapter 10: Hepatocyte Growth Factor/Scatter Factor and Prostate Cancer Metastasis<BR>Gaynor Davies, Wen G. Jiang, and Malcolm D. Mason</P>
<P>Chapter 11: Matrix Degradation in Prostate Cancer<BR>Michael J. Wilson and Akhouri A. Sinha</P>
<P>Chapter 12: The Biology of Bone Metastases from Prostate Cancer and the Role of Bisphosphonates<BR>Noel W. Clarke and Herbert A. Fleisch</P>
<P>Chapter 13: Non-Steroidal Anti-Androgen Use as Part of Combined Androgen Blockade Therapy for Metastatic or Locally Advanced Prostate Cancer: a Review of the Evidence on Efficacy and Toxicity<BR>Mike Shelley, Charles Bennett, Derek Nathan, and Oliver Sartor</P>
<P>Chapter 14: Strategies for the Implementation of Chemotherapy and Radiotherapy<BR>Paula Scullin, Joe M. O’Sullivan, and Christopher C. Parker</P>
<P>Chapter 15: Immuno-gene Therapy for Metastatic Prostate Cancer<BR>Takefumi Satoh, Terry L. Timme, Yehoshua Gdor, Brian J. Miles, Robert J. Amato, Dov Kadmon, and Timothy C. Thompson</P>
<P>Chapter 16: Distilling the Past – Envisioning the Future<BR>Richard J. Ablin and Malcolm D. Mason</P>